{
  "attach_pages": "4",
  "attach_size": "988",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP202001051373514878_1.pdf?1578218189000.pdf",
  "company_code": "10000082",
  "eitime": "2020-01-05 09:56:29",
  "extend": {},
  "info_code": "AP202001051373514878",
  "language": "0",
  "notice_date": "2020-01-05 00:00:00",
  "notice_title": "临床前CRO不断开疆扩土，看好龙头平台优势",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "A",
  "researcher": "李敬雷",
  "security": [
    {
      "market_uni": "1",
      "publish_relation": [
        {
          "originalCode": "727",
          "publishName": "医疗服务"
        }
      ],
      "short_name": "药明康德",
      "short_name_ch": "药明康德",
      "short_name_cht": "藥明康德",
      "short_name_en": "WUXI APPTEC",
      "stock": "603259"
    }
  ],
  "short_name": "药明康德",
  "source_sample_name": "国金证券",
  "star": "5"
}